InvestSMART

Cogstate Limited (ASX: CGS) - Announcements

- Current share price for CGS : $3.040

ASX company news and announcements for Cogstate Limited (CGS) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Cogstate Limited (CGS) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Cogstate Limited (CGS), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Cogstate Limited (CGS)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$517 Change in substantial shareholding from AEF 20 Aug 2026 9:23AM $2.930 $3.040 risen by 3.75%
$517 FY26 Results Investor Briefing 18 Aug 2026 8:19AM $2.790 $3.040 risen by 8.96%
$517 FY26 Financial Results and Operational Update 18 Aug 2026 8:13AM $2.790 $3.040 risen by 8.96%
$517 Dividend/Distribution - CGS 18 Aug 2026 8:12AM $2.790 $3.040 risen by 8.96%
$517 FY26 Annual Report 18 Aug 2026 8:12AM $2.790 $3.040 risen by 8.96%
$517 FY26 Appendix 4E 18 Aug 2026 8:12AM $2.790 $3.040 risen by 8.96%
$517 FY26 App 4G and Corporate Governance Statement 18 Aug 2026 8:12AM $2.790 $3.040 risen by 8.96%
$517 2026 Annual General Meeting 10 Aug 2026 3:22PM $2.660 $3.040 risen by 14.29%
$517 FY26 Full Year Results and Investor Webcast Notification 10 Aug 2026 8:42AM $2.590 $3.040 risen by 17.37%
$517 Notification of cessation of securities - CGS 10 Jul 2026 4:43PM $2.900 $3.040 risen by 4.83%
$517 Application for quotation of securities - CGS 10 Jul 2026 4:38PM $2.900 $3.040 risen by 4.83%
$517 Cogstate 4Q26 and FY26 Business Update 8 Jul 2026 8:25AM $2.800 $3.040 risen by 8.57%
$517 Change in substantial shareholding from AEF 3 Jul 2026 10:43AM $2.710 $3.040 risen by 12.18%
$517 Investor Insights - Webinar Materials 10 Jun 2026 8:25AM $2.590 $3.040 risen by 17.37%
$517 Notification of cessation of securities - CGS 3 Jun 2026 4:44PM $2.500 $3.040 risen by 21.60%
$517 Webinar - Unlocking Sustainable Clinical Trials Growth 1 Jun 2026 8:25AM $2.550 $3.040 risen by 19.22%
$517 Update - Notification of buy-back - CGS 1 Jun 2026 8:24AM $2.550 $3.040 risen by 19.22%
$517 Update - Notification of buy-back - CGS 28 May 2026 8:33AM $2.610 $3.040 risen by 16.48%
$517 Company Secretary Appointment/Resignation 22 May 2026 8:52AM $2.540 $3.040 risen by 19.69%
$517 Change of Director's Interest Notice - KW 22 May 2026 8:21AM $2.540 $3.040 risen by 19.69%
$517 Update - Notification of buy-back - CGS 19 May 2026 9:07AM $2.510 $3.040 risen by 21.12%
$517 Update - Notification of buy-back - CGS 15 May 2026 8:39AM $2.510 $3.040 risen by 21.12%
$517 Update - Notification of buy-back - CGS 14 May 2026 8:25AM $2.480 $3.040 risen by 22.58%
$517 Update - Notification of buy-back - CGS 13 May 2026 8:43AM $2.470 $3.040 risen by 23.08%
$517 Update - Notification of buy-back - CGS 12 May 2026 9:02AM $2.500 $3.040 risen by 21.60%

1 - 25 of 999 results

Page 1 of 40

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.